Biodiscovery V
2
57M
2
1
- Areas of investment
Summary
The usual cause for the fund is to invest in rounds with 6-7 partakers. Despite the Biodiscovery V, startups are often financed by Astellas Venture Management, Sofinnova Partners, Imperial Innovations. The meaningful sponsors for the fund in investment in the same round are Andera Partners, Takeda Ventures, Sofinnova Partners.
Deals in the range of 50 - 100 millions dollars are the general things for fund. The top activity for fund was in 2018. The top amount of exits for fund were in 2018. The fund is generally included in less than 2 deals every year.
Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Crescendo Biologics, LogicBio Therapeutics. The fund has no exact preference in some founders of portfolio startups. Among the most successful fund investment fields, there are Therapeutics, Health Care.
Investments analytics
Analytics
- Total investments
- 2
- Lead investments
- 0
- Exits
- 1
- Investments by industry
- Biotechnology (2)
- Genetics (1)
- Therapeutics (1)
- Health Care (1)
- Investments by region
-
- United Kingdom (1)
- United States (1)
- Peak activity year
- 2017
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 10
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Crescendo Biologics | 30 Apr 2018 | Biotechnology, Health Care, Therapeutics | Early Stage Venture | 70M | England, Cambridge, United Kingdom |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.